Variation Biotechnologies, Inc.

Canada


 
Quantité totale PI 75
Rang # Quantité totale PI 17 813
Note d'activité PI 2,3/5.0    29
Rang # Activité PI 26 874
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

21 4
18 5
26 0
1
 
Dernier brevet 2024 - Compositions of mrna-encoded vir...
Premier brevet 2002 - Immunogenic formulations of vari...
Dernière marque 2022 - VBI VACCINES
Première marque 2011 - LPV

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Compositions of mrna-encoded virus-like particles, compositions of mrna-lipid nanoparticles, and ...
2022 P/S Human vaccines. Pharmaceutical preparation collaborative research and development programs.
Invention Immunotherapeutic compositions. The present disclosure provides compositions and methods useful ...
Invention Compositions and methods for treatment of cytomegalovirus. The present disclosure provides compo...
Invention Vaccine compositions for the treatment of coronavirus. The present disclosure provides compositi...
2021 Invention Vaccines, adjuvants, and methods of generating an immune response. Provided herein are vaccines ...
Invention Vaccines, adjuvants, and methods of generating an immune response. Provided herein are vaccines i...
Invention Vaccine compositions for the treatment of coronavirus. The present disclosure provides compositio...
2020 Invention Immunotherapeutic compositions. The present disclosure provides compositions and methods useful f...
Invention Improved therapeutic composition comprising hepatitis b antigen having s, pre-s1 and pre-s2 prote...
Invention Immunotherapeutic compositions for treatment of glioblastoma multiforme. The present disclosure p...
Invention Immunotherapeutic compositions for treatment of glioblastoma multiforme. The present disclosure ...
2019 Invention Immunogenic compositions for treatment of hepatitis b. The present disclosure provides compositio...
2018 Invention Methods for detection of anti-cytomegalovirus neutralizing antibodies. The present disclosure pro...
Invention Methods and compositions for therapeutic agents. The present disclosure provides inter alia compo...
P/S Pharmaceutical preparations, namely, vaccines used in the prevention and treatment of infectious ...
2017 Invention Compositions and methods for treating viral infections. The present disclosure provides compositi...
Invention Vaccine compositions for treatment of zika virus. The present disclosure provides compositions an...
Invention Compositions and methods for treatment of cytomegalovirus. The present disclosure provides compos...
P/S Pharmaceutical preparations, namely human vaccines used in the prevention and treatment of infect...
2016 Invention Synthetic derivatives of mpl and uses thereof. In one aspect, the present disclosure provides com...
2015 Invention Compositions and methods for treatment of hepatitis c. The present disclosure provides compositio...
2014 Invention Compositions and methods for treating influenza. The present application provides compositions an...
2013 Invention Methods and compositions for therapeutic agents. The present disclosure provides inter alia comp...
Invention Methods for preparing thermostable compositions comprising a lipid component and thermolabile the...
Invention Compositions and methods for treating viral infections. The present disclosure provides composit...
2012 Invention Synthetic derivatives of mpl and uses thereof. In one aspect, the present disclosure provides co...
Invention Synthetic derivatives of mpl and uses thereof. Abstract In one aspect, the present disclosure pro...
Invention Methods for preparing vesicles and formulations produced therefrom. The present disclosure provi...
2011 P/S Pharmaceutical preparation collaborative research and development programs; drug and vaccine form...